Your browser is no longer supported. Please, upgrade your browser.
APLT Applied Therapeutics, Inc. daily Stock Chart
APLT [NASD]
Applied Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.77 Insider Own4.70% Shs Outstand20.84M Perf Week5.12%
Market Cap590.67M Forward P/E- EPS next Y-4.12 Insider Trans-25.07% Shs Float16.55M Perf Month-13.13%
Income-49.20M PEG- EPS next Q-0.69 Inst Own62.30% Short Float7.40% Perf Quarter-41.43%
Sales- P/S- EPS this Y-266.10% Inst Trans3.01% Short Ratio5.01 Perf Half Y-49.73%
Book/sh7.48 P/B3.63 EPS next Y-40.10% ROA-65.90% Target Price- Perf Year219.06%
Cash/sh7.08 P/C3.83 EPS next 5Y- ROE-75.90% 52W Range8.50 - 57.39 Perf YTD-0.59%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-52.74% Beta-
Dividend %- Quick Ratio19.30 Sales past 5Y- Gross Margin- 52W Low219.06% ATR2.18
Employees11 Current Ratio19.30 Sales Q/Q- Oper. Margin- RSI (14)40.28 Volatility6.81% 7.95%
OptionableNo Debt/Eq0.00 EPS Q/Q-15.90% Profit Margin- Rel Volume1.04 Prev Close26.88
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume244.14K Price27.12
Recom1.70 SMA200.44% SMA50-22.93% SMA200-20.36% Volume252,119 Change0.89%
Apr-22-20Initiated Goldman Buy $60
Feb-27-20Initiated Barclays Overweight $64
Jun-10-19Initiated Robert W. Baird Outperform $24
Jun-10-19Initiated Cowen Outperform
Jun-10-19Initiated Citigroup Buy $29
Aug-03-20 05:45PM  
Jul-27-20 05:50PM  
Jul-23-20 12:58PM  
Jul-21-20 09:25AM  
Jul-17-20 05:50PM  
07:00AM  
Jul-10-20 11:30AM  
09:05AM  
Jul-07-20 08:37AM  
Jul-06-20 08:40AM  
06:00AM  
Jul-02-20 08:43AM  
Jun-29-20 11:44AM  
Jun-27-20 02:59PM  
Jun-24-20 08:35AM  
12:02AM  
Jun-23-20 08:47AM  
Jun-22-20 08:54AM  
Jun-19-20 08:49AM  
Jun-17-20 12:00PM  
11:30AM  
Jun-15-20 07:00AM  
Jun-08-20 07:00AM  
Jun-03-20 07:00AM  
May-26-20 07:00AM  
May-12-20 07:00AM  
May-11-20 07:00AM  
Apr-27-20 09:07AM  
Apr-21-20 07:00AM  
Apr-11-20 08:22AM  
Apr-02-20 07:00AM  
Mar-13-20 07:00AM  
Mar-10-20 07:00AM  
Mar-03-20 07:00AM  
Feb-26-20 04:05PM  
Feb-21-20 10:12AM  
Feb-20-20 07:03AM  
Jan-28-20 12:24PM  
Jan-24-20 10:44AM  
Jan-23-20 09:28PM  
Jan-22-20 08:25AM  
Jan-21-20 04:16PM  
Jan-14-20 08:27AM  
Jan-09-20 04:47PM  
10:03AM  
08:39AM  
Jan-08-20 08:27AM  
08:12AM  
07:00AM  
Dec-22-19 01:23PM  
Dec-16-19 07:00AM  
Dec-06-19 07:00AM  
Dec-05-19 07:00AM  
Nov-15-19 07:00AM  
Nov-13-19 07:00AM  
Nov-12-19 07:00AM  
Oct-16-19 07:00AM  
Oct-14-19 06:35AM  
Sep-17-19 07:00AM  
Sep-13-19 07:00AM  
Sep-11-19 12:42PM  
Sep-09-19 08:01AM  
Sep-04-19 07:00AM  
Sep-03-19 10:45AM  
Aug-28-19 07:00AM  
Aug-14-19 03:51PM  
Aug-12-19 07:00AM  
Aug-08-19 07:00AM  
Jun-24-19 07:00AM  
Jun-21-19 07:00AM  
Jun-10-19 10:05AM  
Jun-07-19 07:30AM  
May-28-19 07:30AM  
May-24-19 07:00AM  
May-20-19 10:15PM  
May-08-19 07:11AM  
May-07-19 10:46AM  
May-04-19 05:25PM  
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that is in phase I/II for the treatment of galactosemia; AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy; and AT-003 that is in phase I clinical trial for the treatment diabetic retinopathy. The company's preclinical stage products include AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shendelman ShoshanaPresident and CEOJul 22Option Exercise1.4415,00021,600569,285Jul 22 09:55 PM
Shendelman ShoshanaPresident and CEOJul 22Sale25.6615,000384,876554,285Jul 22 09:55 PM
Shendelman ShoshanaPresident and CEOJul 21Option Exercise1.4415,00021,600569,285Jul 22 09:55 PM
Shendelman ShoshanaPresident and CEOJul 21Sale27.0615,000405,834554,285Jul 22 09:55 PM
Shendelman ShoshanaPresident and CEOJul 20Option Exercise1.4415,00021,600569,285Jul 22 09:55 PM
Shendelman ShoshanaPresident and CEOJul 20Sale27.3415,000410,079554,285Jul 22 09:55 PM
Shendelman ShoshanaPresident and CEOJul 09Option Exercise1.4415,00021,600569,285Jul 09 09:55 PM
Shendelman ShoshanaPresident and CEOJul 09Sale31.1015,000466,507554,285Jul 09 09:55 PM
Shendelman ShoshanaPresident and CEOJul 08Option Exercise1.4415,00021,600569,285Jul 09 09:55 PM
Shendelman ShoshanaPresident and CEOJul 08Sale32.3215,000484,775554,285Jul 09 09:55 PM
Shendelman ShoshanaPresident and CEOJul 07Option Exercise1.4415,00021,600569,285Jul 09 09:55 PM
Shendelman ShoshanaPresident and CEOJul 07Sale32.1715,000482,513554,285Jul 09 09:55 PM
Funtleyder Leslie D.DirectorJun 25Sale37.2781730,45017,148Jun 25 09:45 PM
Funtleyder Leslie D.DirectorJun 24Sale39.887,783310,39317,965Jun 25 09:45 PM
Funtleyder Leslie D.DirectorJun 23Sale44.5411,400507,71225,748Jun 25 09:45 PM
Funtleyder Leslie D.DirectorJun 22Option Exercise4.7020,00094,00037,148Jun 22 09:47 PM
Funtleyder Leslie D.DirectorJun 18Sale45.327,498339,81617,148Jun 22 09:47 PM
Funtleyder Leslie D.DirectorJun 17Sale44.154,100181,01524,646Jun 17 09:50 PM
Funtleyder Leslie D.DirectorJun 16Sale44.385,402239,76828,746Jun 17 09:50 PM
Funtleyder Leslie D.DirectorJun 15Option Exercise4.7017,00079,90034,148Jun 17 09:50 PM
Funtleyder Leslie D.DirectorJun 10Sale42.315,185219,37317,148Jun 10 09:50 PM
Funtleyder Leslie D.DirectorJun 09Sale43.703,500152,94522,333Jun 10 09:50 PM
Funtleyder Leslie D.DirectorJun 08Option Exercise4.7017,00079,90034,148Jun 10 09:50 PM
Funtleyder Leslie D.DirectorJun 08Sale44.778,315372,26325,833Jun 10 09:50 PM
Funtleyder Leslie D.DirectorJun 04Sale44.171,48265,46017,148Jun 04 09:25 PM
Funtleyder Leslie D.DirectorJun 03Sale44.031,03245,43918,630Jun 04 09:25 PM
Funtleyder Leslie D.DirectorJun 02Option Exercise4.7015,00070,50032,148Jun 04 09:25 PM
Funtleyder Leslie D.DirectorJun 02Sale45.2112,486564,49219,662Jun 04 09:25 PM
Funtleyder Leslie D.DirectorMay 29Sale44.7115,615698,15717,148Jun 01 08:17 PM
Shendelman ShoshanaPresident and CEOMay 28Option Exercise1.34125,000167,845679,285Jun 01 07:52 PM
Funtleyder Leslie D.DirectorMay 28Option Exercise0.0418,45373835,601Jun 01 08:17 PM
Funtleyder Leslie D.DirectorMay 28Sale48.272,838136,99032,763Jun 01 08:17 PM
Shendelman ShoshanaPresident and CEOMay 28Sale42.70125,0005,337,500554,285Jun 01 07:52 PM
MARCUS JOEL SDirectorMay 15Sale43.215,823251,603365,360May 15 06:12 PM
MARCUS JOEL SDirectorMay 14Sale43.189,177396,263371,183May 15 06:12 PM
MARCUS JOEL SDirectorMay 13Sale45.3025,0001,132,435380,360May 15 06:12 PM
Lerner TeenaDirectorFeb 06Option Exercise2.4630,42374,71249,593Feb 07 07:25 PM
MARCUS JOEL SDirectorJan 28Buy45.5050022,750405,360Jan 29 04:32 PM
Kanter Stacy J.DirectorJan 28Buy45.506,500295,7506,500Jan 29 04:31 PM